Source: Ceridian HCM Holding Inc.
  • Ceridian (CDAY) has received authorization from the Office of Comptroller of the Currency (OCC) to open Ceridian National Trust Bank on January 3, 2023
  • Banking operations will reduce complexity across multiple jurisdictions
  • Historically, certain aspects of Ceridian’s US client money movement activity have been subject to regulation at both the federal and individual state levels
  • Ceridian (CDAY) is a global human capital management software company
  • Ceridian (CDAY) is trading at C$84.88 as of 3:05 pm ET

Ceridian (CDAY) has been authorized to open Ceridian National Trust Bank on January 3, 2023.

Effective on this day, the Ceridian National Trust Bank commenced banking operations, acting as trustee for Ceridian’s US payroll trust.

Historically, certain aspects of Ceridian’s US client money movement activity have been subject to regulation at both the federal and individual state levels. Resulting in inherent complexity across multiple jurisdictions. With the establishment of the Ceridian National Trust Bank, regulatory oversight will now be under the OCC, a single federal government agency.

Ceridian’s payroll trust structure will continue to benefit Ceridian customers by providing bankruptcy-remoteness protection for client funds pending remittance to employees of our clients, tax authorities, and other payees.

Ceridian (CDAY) is a global human capital management software company.

Ceridian (CDAY) is trading at C$84.88 as of 3:05 pm ET.


More From The Market Online

ESE producing championship e-sports tournament for Riot Games

ESE Entertainment’s (TSXV:ESE) media production unit, Frenzy, takes on the distribution of the upcoming Teamfight Tactics e-sports tournament.

York Harbour Metals reveals more promising rare earth sampling assays

York Harbour Metals (TSXV:YORK) reports encouraging findings in its latest Bottom Brook Rare Earth Elements project analysis.

Optimi Health makes first international MDMA shipment

Optimi Health (CSE:OPTI) makes its first international shipment of MDMA to The Institute for Psychedelic Research at Tel Aviv University.

Oncolytics Biotech approved to expand pancreatic cancer program

Oncolytics Biotech (TSX:ONC), a cancer immunotherapy stock, receives ethics and German regulatory approvals for a new pancreatic cancer study.